Research Studies
Published research on HBOT for Multiple Sclerosis
← Browse all conditions in the PubMed Research LibraryThese publications include different levels of evidence—not necessarily clinical trials. PubMed indexing is not proof of benefit or an endorsement. Summaries are based on available PubMed abstracts, not a formal full-text quality assessment. Read the limitations as well as the findings; some papers report no benefit or potential harms.
Randomized placebo-controlled trial 1987
Hyperbaric oxygen and multiple sclerosis: final results of a placebo-controlled, double-blind trial. (opens PubMed in a new tab)
Barnes MP; Bates D; Cartlidge NE; French JM; Shaw DA — Journal of neurology, neurosurgery, and psychiatry
Plain English Summary
HBOT did not alter multiple sclerosis progression or relapse rates in this long-term follow-up; most outcomes did not differ from placebo.
Limitations & context: One functional measure favored treatment, but objective bladder tests did not confirm earlier subjective improvement and visual changes raised safety concerns.
Medical Disclaimer
This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting HBOT or any treatment. Individual results may vary.